0001703341-17-000003.txt : 20170427 0001703341-17-000003.hdr.sgml : 20170427 20170427123232 ACCESSION NUMBER: 0001703341-17-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170427 DATE AS OF CHANGE: 20170427 EFFECTIVENESS DATE: 20170427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corino Therapeutics, Inc. CENTRAL INDEX KEY: 0001703341 IRS NUMBER: 814377816 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285612 FILM NUMBER: 17787463 BUSINESS ADDRESS: STREET 1: C/O PETER BARBER STREET 2: 57 WEST 57TH STREET 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 430-1740 MAIL ADDRESS: STREET 1: C/O PETER BARBER STREET 2: 57 WEST 57TH STREET 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0707 D LIVE 0001703341 Corino Therapeutics, Inc. PETER BARBER 57 WEST 57TH STREET 18TH FLOOR NEW YORK NY NEW YORK 10019 (212) 430-1740 DELAWARE None None Corporation true 2016 Daniel DiPietro 57 West 57th Street 18th Floor New York NY NEW YORK 10019 Executive Officer Director Peter Barber 57 West 57th Street 18th Floor New York NY NEW YORK 10019 Director Timothy McInerney 57 West 57th Street 18th Floor New York NY NEW YORK 10019 Director Jay Moorin 57 West 57th Street 18th Floor New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06b false 2017-04-13 false true true false 0 Castle Hill Capital Partners, Inc. 44131 Castle Hill Capital Partners, Inc. 44131 216 E. 45th Street New York NY NEW YORK 10017 All States false ROTH Capital Partners 15407 ROTH Capital Partners 15407 57 West 57th Street 18th Floor New York NY NEW YORK 10019 All States false 5000000 3474000 1526000 false 27 208440 0 In addition to the cash commission above, Issuer also issued warrants to purchase a number of shares of Issuer's Common Stock equal to 5% of the aggregate amount of shares into which the Notes sold in the offering eventually are convertible. 208440 true One of our directors also served as our independent investment banker for this transaction through the auspices of a FINRA firm. false Corino Therapeutics, Inc. /s/ Peter Barber Peter Barber Secretary 2017-04-24